Inizio today announced a significant expansion of its Global Medical Information capabilities through Inizio Engage, introducing Connected Insights to help pharmaceutical and biotechnology companies transform Medical Information from a responsive support function into a strategic source of intelligence. Combining expanded Asia-Pacific (APAC) expertise, enhanced global infrastructure, and AI-enabled innovation, the investment enables organizations to generate actionable insights from every scientific interaction while delivering consistent, high-quality Medical Information at global scale.
The investment builds on one of the industry’s largest Global Medical Information organizations, supporting:
As therapies become increasingly specialized and scientific engagement grows more complex, Medical Information teams are expected to do far more than answer inquiries. Organizations are looking to identify emerging trends, better understand healthcare professional and patient needs, and generate insights that strengthen Medical Affairs strategy, all while maintaining scientific accuracy, regulatory compliance, and exceptional customer experiences. Our Connected Insights ensures the value of every Medical Information interaction extends beyond the individual inquiry turning real-world engagement data into actionable intelligence that informs strategy, uncovers opportunities, and creates value across a client’s entire portfolio.
“Medical Information has become one of the richest sources of scientific insight across the product lifecycle,” said Jenny Reid-Young, Vice President, Global Medical Information, Inizio Engage. “Organizations that can connect those interactions across markets and translate them into meaningful intelligence will make better decisions, improve customer experiences and strengthen Medical Affairs strategy. Our expanded capabilities are designed to help clients do exactly that, combining global consistency with local expertise while unlocking greater value from every scientific interaction.”
Designed to support organizations operating across global and regional markets, Inizio Engage delivers Medical Information programs in more than 20 languages, combining the simplicity of a single global partner with deep local expertise. Its globally connected teams understand the regulatory, cultural, linguistic and healthcare system requirements unique to each market, ensuring every program is delivered with consistency, scientific rigor and compliance.
The expansion includes:
Amy Van Sant, Global President, Medical Affairs, Inizio Engage, added: “By combining scientific expertise with AI-enabled capabilities and global scale, we’re helping clients unlock significantly more value from every interaction and redefine what’s possible through Global Medical Information.”
These investments reinforce Inizio’s broader commitment to Intelligent Commercialization™, connecting scientific expertise, technology and data-driven insight to help life sciences organizations make better decisions, improve engagement and deliver stronger outcomes across the product lifecycle.
Jump to a slide with the slide dots.
CASE STUDY (US) Improving MI Call Center Efficiencies and Customer Experience with AI Virtual Agents
Leer más
CASE STUDY (UK) Discover how Inizio Engage deployed a scalable MSL team to enhance public health engagement, improve vaccine access and drive...
Leer más
INKA shows how AI can make healthcare inbound customer service more structured, transparent and efficient.
Leer más
Discover how Pipeline Medical Science Liaisons improve clinical trial recruitment, site engagement, and operational efficiency across development..
Leer más